|
US20030050273A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Keiya Ozawa |
Compositions and methods for treating neurodegenerative diseases
|
|
WO2006063247A2
(en)
*
|
2004-12-09 |
2006-06-15 |
Genzyme Corporation |
Regulated expression of transgenes in the central nervous system of mammals
|
|
US10738326B2
(en)
*
|
2010-10-27 |
2020-08-11 |
Jichi Medical University |
Adeno-associated virus vector for gene transfer to nervous system cells
|
|
GB201118636D0
(en)
*
|
2011-10-28 |
2011-12-07 |
Oxford Biomedica Ltd |
Nucleotide sequence
|
|
LT3137497T
(lt)
*
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
EP3215191B1
(en)
*
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
AU2016259976B2
(en)
*
|
2015-05-08 |
2021-10-14 |
Children's Medical Research Institute |
Promoters for expression of heterologous genes
|
|
ES2831764T3
(es)
*
|
2016-04-29 |
2021-06-09 |
Orphazyme As |
Arimoclomol para el tratamiento de trastornos asociados a glucocerebrosidasa
|
|
WO2017191274A2
(en)
*
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
EP3692158A4
(en)
*
|
2017-10-03 |
2021-08-04 |
Prevail Therapeutics, Inc. |
GENE THERAPIES FOR LYSOSOMAL DISEASES
|
|
WO2019068854A1
(en)
*
|
2017-10-06 |
2019-04-11 |
Ospedale San Raffaele S.R.L. |
GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS
|
|
MX2020004035A
(es)
*
|
2017-10-20 |
2020-11-09 |
Res Inst Nationwide Childrens Hospital |
Métodos y materiales para terapia génica con nt-3.
|
|
AU2018354195A1
(en)
*
|
2017-10-23 |
2020-06-04 |
Prevail Therapeutics, Inc. |
Gene therapies for neurodegenerative disease
|
|
CN108841868A
(zh)
*
|
2018-05-31 |
2018-11-20 |
康霖生物科技(杭州)有限公司 |
一种用于中枢神经系统疾病治疗的基因序列构建体
|
|
CN109266648B
(zh)
*
|
2018-09-26 |
2021-10-19 |
中国科学技术大学 |
用于在体基因治疗的基因编辑组合物或试剂盒
|
|
BR112021009913A2
(pt)
*
|
2018-12-05 |
2021-08-17 |
Abeona Therapeutics, Inc. |
vetor viral adeno-associado recombinante para inserção gênica
|
|
JP7664848B2
(ja)
*
|
2019-04-10 |
2025-04-18 |
プリベイル セラピューティクス,インコーポレーテッド |
リソソーム障害のための遺伝子療法
|
|
HRP20251506T1
(hr)
*
|
2019-04-10 |
2026-01-02 |
Prevail Therapeutics, Inc. |
Genska terapija za lizosomske poremećaje
|
|
CA3149844A1
(en)
*
|
2019-08-12 |
2021-02-18 |
Fundacion Para La Investigacion Medica Aplicada |
Viral particles for use in treating synucleinopathies such as parkinson's diseases by gene therapy
|
|
US20230047254A1
(en)
*
|
2019-12-29 |
2023-02-16 |
Gloriana Therapeutics |
Mammalian Cells Secreting GDNF and Their Therapeutic Use
|
|
CN113755524B
(zh)
*
|
2020-06-02 |
2023-11-03 |
舒泰神(北京)生物制药股份有限公司 |
用于治疗脊髓性肌萎缩的腺相关病毒载体及其用途
|
|
EP4192514A1
(en)
*
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
CA3238867A1
(en)
*
|
2021-11-29 |
2023-06-01 |
Shanghai Regenelead Therapies Co., Ltd. |
Aadc/gdnf polynucleotide, and use thereof in treating parkinson's disease
|
|
CN114317610B
(zh)
*
|
2022-01-27 |
2024-07-02 |
上海本导基因技术有限公司 |
一种适用于帕金森疾病基因治疗的慢病毒载体
|